Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

TSCM, GRHU, AEHR, CYTK - Stock Updates! from CRWEfinance.com

crwefinancelogo2

signup3m

___

TheStreet.com, Inc. (Nasdaq:TSCM) announced that its board of directors has declared the Company's quarterly cash dividend on its common stock. The cash dividend of $0.025 per share of common stock will be payable December 31, 2010, to all shareholders of record at the close of business on December 15, 2010.

TheStreet.com, Inc., together with its subsidiaries, operates as a digital financial media company in the United States. The company provides various subscription-based and advertising-supported content and tools to its readers and advertisers through a range of online platforms, including Web sites, mobile devices, email services, widgets, blogs, podcasts, and online video channels.

********************************

GreenHouse Holdings, Inc. (OTCQB:GRHU)

GreenHouse Holdings, Inc., a leading provider of energy efficiency solutions and sustainable infrastructure products, announced this week that it has been engaged to utilize Southern California Edison's (SCE) Automated Demand Response (Auto-DR) program in Gulfstream Aerospace Corporation's Long Beach, CA facility. GRHU is a qualified service provider of SCE's Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies and complete processing of all incentives.

The Auto-DR program offers significant financial incentives and technical support to SCE customers with automated load control systems that participate in demand response events. Auto-DR uses control systems to automatically achieve specified energy demand reductions (kW and duration) during periods of peak energy consumption. In utilizing the Auto-DR system, Gulfstream will reduce electric consumption during costly peak energy periods when the demand is highest. Additionally, the system provides Gulfstream the ability to reduce operating costs by curtailing the use and purchase of electricity. Gulfstream will then receive financial incentives from SCE.

"Auto-DR is just one of the innovative services Greenhouse offers to help our clients reduce energy consumption by deploying state-of-the-art technology," says Rob Davis, Vice President of GRHU. "We are truly honored to be selected by Gulfstream and we are looking forward to the Auto-DR project as the first of many services offered in support of Gulfstream's corporate energy stewardship initiatives. This project goes to the heart of Greenhouse's mission to deliver sustainable solutions that reduce energy consumption with a positive return on investment."

To learn more about GRHU visit: http://www.greenhouseintl.com

********************************

Aehr Test Systems (Nasdaq:AEHR) announced this week that it will report financial results for the second quarter of fiscal 2011 ended November 30, 2010 after the market closes on Thursday, January 6, 2011. Management of Aehr Test Systems will host a conference call and webcast that same day at 5:00 p.m. Eastern (2:00 p.m. Pacific) to discuss the Company's operating performance. The conference call will be accessible live via the internet at www.aehr.com. Please go to the website at least 15 minutes before start time to register, download and install any necessary audio software. A replay of the webcast will be available for 90 days.

Aehr Test Systems develops, manufactures, and sells systems, which are designed to reduce the cost of testing flash, dynamic random access memory, and other memory devices, and to perform reliability screening or burn-in of complex logic and memory devices. The company manufactures and markets full wafer contact systems, monitored burn-in systems, massively parallel test systems, test fixtures, die carriers, and related accessories.

********************************

Cytokinetics Inc. (Nasdaq:CYTK) announced the successful completion of its Phase IIa "Evidence of Effect" (EoE) clinical trial of CK-2017357 in patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, during an oral presentation included in the Clinical Trials Session at the 21st International Symposium on ALS/MND in Orlando, Florida. A presentation titled, "A Phase 2A, Double-Blind, Randomized, Placebo-Controlled, Single-dose, Crossover Study of the Selective Fast Skeletal Muscle Troponin Activator, CK-2017357, in Patients with ALS" was made by Jeremy M. Shefner, MD, PhD, Professor and Chair of the Department of Neurology at the Upstate Medical University at the State University of New York. CK-2017357 is the lead drug candidate from the company's skeletal muscle contractility program.

Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule drug therapeutics for the treatment of cardiovascular diseases and cancer. The company’s lead product includes CK-1827452, a cardiac muscle myosin activator, which is in Phase IIa clinical trials for the treatment of heart failure.

___

********************************************************************

http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (OTCQB:GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.